Review of Intravenous and Subcutaneous Electronic Glucose Management Systems for Inpatient Glycemic Control
- 9 November 2020
- journal article
- review article
- Published by Springer Nature in Current Diabetes Reports
- Vol. 20 (12) , 1-9
Abstract
Purpose of Review The goal of this review is to summarize current literature on electronic glucose management systems (eGMS) and discuss their benefits and disadvantages in the inpatient setting. Recent Findings We review different versions of commercially available eGMS: Glucommander™ (Glytec, Greenville, SC), EndoToolR (MD Scientific LLC, Charlotte, NC), GlucoStabilizer™ (Medical Decision Network, Charlottesville, VA), GlucoCare™ (Pronia Medical Systems, KY), and discuss advantages such as reducing rates of hypoglycemia, hyperglycemia, and glycemic variability. In addition, eCGMs offer a uniform standard of care and may improve workflows across institutions as well reduce barriers. Summary Despite ample literature on intravenous (IV) versions of eGMS, there is little published research on subcutaneous (SQ) insulin guidance. Although use of eGMS requires extensive training and institution-wide adoption, time spent on diabetes management is better facilitated by their use.Keywords
This publication has 39 references indexed in Scilit:
- Software-Guided Insulin Dosing: Tight Glycemic Control and Decreased Glycemic Derangements in Critically Ill PatientsMayo Clinic Proceedings, 2013
- Hypoglycemia and Risk of Death in Critically Ill PatientsNew England Journal of Medicine, 2012
- Effect of a Computerized Insulin Dose Calculator on the Process of Glycemic ControlAmerican Journal of Critical Care, 2012
- Computer Decision Support Software Safely Improves Glycemic Control in the Burn Intensive Care Unit: A Randomized Controlled Clinical StudyJournal of Burn Care & Research, 2011
- A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer‐guided vs. standard column‐based algorithmsJournal of Hospital Medicine, 2010
- The impact of early hypoglycemia and blood glucose variability on outcome in critical illnessCritical Care, 2009
- The Contribution of Malglycemia to Mortality among Allogeneic Hematopoietic Cell Transplant RecipientsTransplantation and Cellular Therapy, 2009
- Severe hypoglycemia in critically ill patients: Risk factors and outcomes*Critical Care Medicine, 2007
- Variability of Blood Glucose Concentration and Short-term Mortality in Critically Ill PatientsAnesthesiology, 2006
- Intensive Insulin Therapy in Critically Ill PatientsNew England Journal of Medicine, 2001